Tribune Therapeutics AB
559281-1045ActiveDeveloping novel medicines to halt fibrotic disease progression across organs.
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Georg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Beskrivelse
Tribune Therapeutics is a preclinical biopharmaceutical company established in 2020, focused on creating novel medicines for treating fibrosis. Their core mission is to address fibrotic diseases regardless of the underlying cause or affected tissue, such as the heart, kidneys, or lungs. The company'...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559281104501
Beslutningstagere
4 kontakter i FunnelfeedrGeorg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrAQILION AB
5–9 medarbejdereDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
CALLUNA PHARMA AS
10 medarbejdereClinical stage biotech pioneering antibodies for inflammation and fibrosis.
CANTARGIA AB
20–49 medarbejdereDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
PILA PHARMA AB
1–4 medarbejdereClinical stage biotech developing an oral obesity and diabetes treatment.
AcroPharma AB (publ)
0 medarbejdereDeveloping innovative preventive therapeutics for major human diseases.
Udforsk mere
Spørgsmål om Tribune Therapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo